EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:49845 - (R)-quinacrine
| Formula | C23H30ClN3O |
| Net Charge | 0 |
| Average Mass | 399.966 |
| Monoisotopic Mass | 399.20774 |
| SMILES | CCN(CC)CCC[C@@H](C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 |
| InChI | InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26)/t16-/m1/s1 |
| InChIKey | GPKJTRJOBQGKQK-MRXNPFEDSA-N |
| Roles Classification |
|---|
| Chemical Roles: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor An EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of trypanothione-disulfide reductase (EC 1.8.1.12). |
| Application: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (R)-quinacrine (CHEBI:49845) is a quinacrine (CHEBI:8711) |
| (R)-quinacrine (CHEBI:49845) is enantiomer of (S)-quinacrine (CHEBI:37597) |
| Incoming Relation(s) |
| (S)-quinacrine (CHEBI:37597) is enantiomer of (R)-quinacrine (CHEBI:49845) |
| IUPAC Name |
|---|
| (4R)-N4-(6-chloro-2-methoxyacridin-9-yl)-N1,N1-diethylpentane-1,4-diamine |
| Synonym | Source |
|---|---|
| QUINACRINE | PDBeChem |
| Manual Xrefs | Databases |
|---|---|
| QUN | PDBeChem |